Search Results - "Sogo, Naoki"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Inhibition of Human Platelet Aggregation by Nitric Oxide Donor Drugs: Relative Contribution of cGMP-Independent Mechanisms by Sogo, Naoki, Magid, Kesson S., Shaw, Catherine A., Webb, David J., Megson, Ian L.

    “…Inhibition of platelet activation by nitric oxide (NO) is not exclusively cGMP-dependent. Here, we tested whether inhibition of platelet aggregation by…”
    Get full text
    Journal Article
  2. 2

    Marker genes to predict sensitivity to FK228, a histone deacetylase inhibitor by Sasakawa, Yuka, Naoe, Yoshinori, Sogo, Naoki, Inoue, Takeshi, Sasakawa, Tatsuya, Matsuo, Masahiko, Manda, Toshitaka, Mutoh, Seitaro

    Published in Biochemical pharmacology (15-02-2005)
    “…In this study, we detected genes sensitive to an histone deacetylase inhibitor, FK228 [( E)-(1 S,4 S,10 S,21 R)-7-[(…”
    Get full text
    Journal Article
  3. 3

    S‐Nitrosothiols cause prolonged, nitric oxide‐mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery by Sogo, Naoki, Campanella, Ciro, Webb, David J, Megson, Ian L

    Published in British journal of pharmacology (01-11-2000)
    “…Reduced endothelial nitric oxide (NO) production in conduit vessels for coronary artery bypass grafting (CABG) has been implicated in post‐operative…”
    Get full text
    Journal Article
  4. 4

    Inhibition of human platelet aggregation by a novel S‐nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti‐thrombotic therapy by Megson, Ian L, Sogo, Naoki, Mazzei, Francesca A, Butler, Anthony R, Walton, John C, Webb, David J

    Published in British journal of pharmacology (01-12-2000)
    “…S‐Nitrosothiols are nitric oxide (NO) donor drugs that have been shown to inhibit platelet aggregation in platelet rich plasma (PRP) in vitro and to inhibit…”
    Get full text
    Journal Article
  5. 5

    A novel S‐nitrosothiol (RIG200) causes prolonged relaxation in dorsal hand veins with damaged endothelium by Sogo, Naoki, Wilkinson, Ian B., MacCallum, Helen, Khan, Sohail Q., Strachan, Fiona E., Newby, David E., Megson, Ian L., Webb, David J.

    Published in Clinical pharmacology and therapeutics (01-07-2000)
    “…Background Reduced nitric oxide bioavailability caused by endothelial dysfunction or damage is a contributory factor in the initiation and progression of a…”
    Get full text
    Journal Article